Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_assertion type Assertion NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_head.
- NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_assertion description "[Thus, this study strongly suggests that pooled gp96 vaccines from myeloma cell lines can replace gp96 vaccines from autologous tumors for immunotherapy and induce immune responses against broader tumor antigens that may protect against tumor recurrence and development of unrelated tumors in vaccinated myeloma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_provenance.
- NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_assertion evidence source_evidence_literature NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_provenance.
- NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_assertion SIO_000772 19654406 NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_provenance.
- NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_assertion wasDerivedFrom befree-2016 NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_provenance.
- NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_assertion wasGeneratedBy ECO_0000203 NP755416.RAelCPpMFPf7dy_tJRrKUK4siJ3FjYsetmzvyzy0p_3Bo130_provenance.